On the public citation graph
Tumor-infiltrating immune cell subpopulations influence the oncologic outcome after intravesical Bacillus Calmette-Guérin therapy in bladder cancer
0 signed · 223 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/eji.200737888openalex-snapshot
Accelerating the secondary immune response by inactivating CD4+CD25+ T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis
inferredcites →https://doi.org/10.1002/ijc.11352openalex-snapshot
Urinary IL‐2 assay for monitoring intravesical bacillus Calmette‐Guérin response of superficial bladder cancer during induction course and maintenance therapy
inferredcites →https://doi.org/10.1002/ijc.28233openalex-snapshot
Antitumor T cell responses in bladder cancer are directed against a limited set of antigens and are modulated by regulatory T cells and routine treatment approaches
inferredcites →https://doi.org/10.1002/jcla.21532openalex-snapshot
Alterations of Dendritic Cell Subsets and T h1/ T h2 Cytokines in the Peripheral Circulation of Patients With Superficial Transitional Cell Carcinoma of the Bladder
inferredcites →https://doi.org/10.1007/s00262-003-0384-9openalex-snapshot
Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Gu�rin immunotherapy for carcinoma in situ of the bladder
inferredcites →https://doi.org/10.1007/s00262-014-1651-7openalex-snapshot
Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma
inferredcites →https://doi.org/10.1007/s00345-009-0492-zopenalex-snapshot
Tumor-associated macrophages in clear cell renal cell carcinoma express both gastrin-releasing peptide and its receptor: a possible modulatory role of immune effectors cells
inferredcites →https://doi.org/10.1007/s00345-012-0974-2openalex-snapshot
First analysis of immune cell infiltration in stage pT1 urothelial bladder carcinoma: CD3 positivity as a prognostic marker for cancer-specific survival
inferredcites →https://doi.org/10.1007/s00345-015-1615-3openalex-snapshot
The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer
inferredcites →https://doi.org/10.1007/s10549-010-0987-8openalex-snapshot
An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer
inferredcites →https://doi.org/10.1016/j.clgc.2015.01.005openalex-snapshot
Development of Predictive Value of Urinary Cytokine Profile Induced During Intravesical Bacillus Calmette-Guérin Instillations for Bladder Cancer
inferredcites →https://doi.org/10.1016/j.eururo.2005.03.021openalex-snapshot
Cystectomy in Patients with High Risk Superficial Bladder Tumors Who Fail Intravesical BCG Therapy:
inferredcites →https://doi.org/10.1016/j.eururo.2009.01.040openalex-snapshot
Bladder Tumor Infiltrating Mature Dendritic Cells and Macrophages as Predictors of Response to Bacillus Calmette-Guérin Immunotherapy
inferredcites →https://doi.org/10.1016/j.eururo.2011.09.026openalex-snapshot
Markers Predicting Response to Bacillus Calmette-Guérin Immunotherapy in High-Risk Bladder Cancer Patients: A Systematic Review
inferredcites →https://doi.org/10.1016/j.eururo.2013.06.003openalex-snapshot
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
inferredcites →https://doi.org/10.1016/j.eururo.2014.11.031openalex-snapshot
Therapeutic Options in High-risk Non–muscle-invasive Bladder Cancer During the Current Worldwide Shortage of Bacille Calmette-Guérin
inferredcites →https://doi.org/10.1016/j.eururo.2015.06.023openalex-snapshot
Cytokine Panel for Response to Intravesical Therapy (CyPRIT): Nomogram of Changes in Urinary Cytokine Levels Predicts Patient Response to Bacillus Calmette-Guérin
inferredcites →https://doi.org/10.1016/j.juro.2006.03.038openalex-snapshot
Cystectomy for Transitional Cell Carcinoma of the Bladder: Results of a Surgery Only Series in the Neobladder Era
inferredcites →https://doi.org/10.1016/j.juro.2006.08.078openalex-snapshot
Human Bladder Carcinoma is Dominated by T-Regulatory Cells and Th1 Inhibitory Cytokines
inferredcites →https://doi.org/10.1016/j.juro.2006.11.090openalex-snapshot
Treatment Paradigm Shift May Improve Survival of Patients With High Risk Superficial Bladder Cancer
inferredcites →https://doi.org/10.1016/j.juro.2008.11.090openalex-snapshot
Increased Infiltration of Tumor Associated Macrophages is Associated With Poor Prognosis of Bladder Carcinoma In Situ After Intravesical Bacillus Calmette-Guerin Instillation
inferredcites →https://doi.org/10.1016/j.juro.2016.10.101openalex-snapshot
Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors
inferredcites →https://doi.org/10.1016/j.rmed.2003.12.003openalex-snapshot
Analysis of local T lymphocyte subsets upon stimulation with intravesical BCG: A model to study tuberculosis immunity
inferredcites →https://doi.org/10.1016/j.urolonc.2009.06.002openalex-snapshot
A disproportion of TH1/TH2 cytokines with predominance of TH2, in urothelial carcinoma of bladder
inferredcites →https://doi.org/10.1016/j.urolonc.2013.06.008openalex-snapshot
Predicting response to bacillus Calmette-Guérin (BCG) in patients with carcinoma in situ of the bladder
inferredcites →https://doi.org/10.1016/j.urolonc.2013.10.012openalex-snapshot
The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure
inferredcites →https://doi.org/10.1016/j.urolonc.2014.02.007openalex-snapshot
Infiltration of CD3+ and CD68+ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors
inferredcites →https://doi.org/10.1016/s0022-5347(05)65522-xopenalex-snapshot
T HELPER 1/2 LYMPHOCYTE URINARY CYTOKINE PROFILES IN RESPONDING AND NONRESPONDING PATIENTS AFTER 1 AND 2 COURSES OF BACILLUS CALMETTE-GUERIN FOR SUPERFICIAL BLADDER CANCER
inferredcites →https://doi.org/10.1016/s0022-5347(17)58737-6openalex-snapshot
Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors
inferredcites →https://doi.org/10.1016/s1043-4666(02)00490-8openalex-snapshot
Role of Th1 and Th2 cytokines in BCG-induced IFN-γ production: cytokine promotion and simulation of BCG effect
inferredcites →https://doi.org/10.1038/nrc1256openalex-snapshot
Tumour-educated macrophages promote tumour progression and metastasis
inferredcites →https://doi.org/10.1073/pnas.0611618104openalex-snapshot
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma
inferredcites →https://doi.org/10.1074/jbc.m114.558098openalex-snapshot
Small Molecule-directed Immunotherapy against Recurrent Infection by Mycobacterium tuberculosis
inferredcites →https://doi.org/10.1074/jbc.m114.600452openalex-snapshot
Simultaneous Inhibition of T Helper 2 and T Regulatory Cell Differentiation by Small Molecules Enhances Bacillus Calmette-Guerin Vaccine Efficacy against Tuberculosis
inferredcites →https://doi.org/10.1097/jto.0b013e3181d60fd7openalex-snapshot
Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small Cell Lung Cancer
inferredcites →https://doi.org/10.1111/j.1365-2249.2012.04614.xopenalex-snapshot
Is interferon-gamma the right marker for bacille Calmette–Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology
inferredcites →https://doi.org/10.1111/j.1442-2042.1997.tb00143.xopenalex-snapshot
Immunohistochemical Study of Tumor‐Infiltrating Lymphocytes Before and After Intravesical Bacillus Calmette‐Guérin Treatment for Superficial Bladder Cancer
inferredcites →https://doi.org/10.1111/j.1464-410x.2010.10020.xopenalex-snapshot
FOXP3 and survival in urinary bladder cancer
inferredcites →https://doi.org/10.1126/scitranslmed.3003586openalex-snapshot
Preexisting BCG-Specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer
inferredcites →https://doi.org/10.1128/jvi.78.23.13082-13089.2004openalex-snapshot
CD4 + CD25 + T Cells Regulate Vaccine-Generated Primary and Memory CD8 + T-Cell Responses against Herpes Simplex Virus Type 1
inferredcites →https://doi.org/10.1128/jvi.79.12.7860-7867.2005openalex-snapshot
T Cells with a CD4 + CD25 + Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8 + T Cells during Chronic Hepatitis C Virus Infection
inferredcites →https://doi.org/10.1155/2011/865684openalex-snapshot
Tumor and Microenvironment Modification during Progression of Murine Orthotopic Bladder Cancer
inferredcites →https://doi.org/10.1177/0394632015584733openalex-snapshot
Immunohistochemical pattern of T lymphocytes population within bilharzial-associated bladder neoplasm microenvironment
inferredcites →https://doi.org/10.1186/1471-2407-12-306openalex-snapshot
The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients
inferredcites →https://doi.org/10.1186/1756-9966-32-87openalex-snapshot
Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer
inferredcites →https://doi.org/10.1200/jco.2006.09.4565openalex-snapshot
Intratumoral Balance of Regulatory and Cytotoxic T Cells Is Associated With Prognosis of Hepatocellular Carcinoma After Resection
inferredcites →https://doi.org/10.1371/journal.pone.0133552openalex-snapshot
Tumor-Associated Macrophages Provide Significant Prognostic Information in Urothelial Bladder Cancer
inferredcites →https://doi.org/10.18632/oncotarget.7024openalex-snapshot
Residual tumor micro-foci and overwhelming regulatory T lymphocyte infiltration are the causes of bladder cancer recurrence
inferredcites →https://doi.org/10.18632/oncotarget.7199openalex-snapshot
Frequency of CD4+CD25+Foxp3+ cells in peripheral blood in relation to urinary bladder cancer malignancy indicators before and after surgical removal
inferredcites →https://doi.org/10.3109/01913123.2012.728688openalex-snapshot
Prognostic Value of Tumor-associated Macrophages Count in Human Non-muscle-invasive Bladder Cancer Treated by BCG Immunotherapy
inferredcites →https://doi.org/10.3390/cancers3033055openalex-snapshot
Immunotherapy for Urothelial Carcinoma: Current Status and Perspectives
inferredcites →https://doi.org/10.4049/jimmunol.172.11.7200openalex-snapshot
Adenovirus CD40 Ligand Gene Therapy Counteracts Immune Escape Mechanisms in the Tumor Microenvironment
inferredcites →https://doi.org/10.4049/jimmunol.175.11.7264openalex-snapshot
Anti-CD25 Antibody Enhancement of Vaccine-Induced Immunogenicity: Increased Durable Cellular Immunity with Reduced Immunodominance
inferredcites →https://doi.org/10.4161/onci.20640openalex-snapshot
Blocking IL-10 enhances bacillus Calmette-Guérin induced T helper Type 1 immune responses and anti-bladder cancer immunity
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4812979openalex-extracted
Toxoplasma Gondii Infection Supports the Infiltration of T Cells into Brain Tumors
inferred← citeshttps://doi.org/10.1002/1878-0261.70329openalex-snapshot
Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review
inferred← citeshttps://doi.org/10.1002/path.5306openalex-snapshot
Bladder cancer, a unique model to understand cancer immunity and develop immunotherapy approaches
inferred← citeshttps://doi.org/10.1002/path.5830openalex-snapshot
BCG invokes superior STING ‐mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-67951-4_8openalex-snapshot
The Microbiome and Urologic Cancers
inferred← citeshttps://doi.org/10.1007/978-3-030-80962-1_199-1openalex-snapshot
BCG Immunotherapy: Old Tool and New Concepts
inferred← citeshttps://doi.org/10.1007/978-3-031-68505-7_20openalex-snapshot
Mechanisms and Biomarkers of Response to BCG and Chemotherapy in Bladder Cancer
inferred← citeshttps://doi.org/10.1007/978-3-032-00767-4_199openalex-snapshot
BCG Immunotherapy: Old Tool and New Concepts
inferred← citeshttps://doi.org/10.1007/s00262-016-1945-zopenalex-snapshot
Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer
inferred← citeshttps://doi.org/10.1007/s00262-019-02443-4openalex-snapshot
Mechanisms of immune evasion in bladder cancer
inferred← citeshttps://doi.org/10.1007/s00262-023-03376-9openalex-snapshot
Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer
inferred← citeshttps://doi.org/10.1007/s00345-020-03329-2openalex-snapshot
PD-L1 expression and pattern of immune cells in pre-treatment specimens are associated with disease-free survival for HR-NMIBC undergoing BCG treatment
inferred← citeshttps://doi.org/10.1007/s00428-020-02759-yopenalex-snapshot
Immune checkpoint status and tumor microenvironment in vulvar squamous cell carcinoma
inferred← citeshttps://doi.org/10.1007/s10549-016-4041-3openalex-snapshot
Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer
inferred← citeshttps://doi.org/10.1007/s11255-019-02183-5openalex-snapshot
Prediction of BCG responses in non-muscle-invasive bladder cancer in the era of novel immunotherapeutics
inferred← citeshttps://doi.org/10.1007/s12026-025-09624-7openalex-snapshot
Phenotypic characterization of tumor associated macrophages and circulating monocytes in patients with Urothelial carcinoma of bladder
inferred← citeshttps://doi.org/10.1007/s12672-025-03244-1openalex-snapshot
Knockdown of CSF1R molecules enhances the antitumor effects of CD8+ T lymphocytes in bladder cancer
inferred← citeshttps://doi.org/10.1016/j.ajpath.2019.10.018openalex-snapshot
Amplification of 7p12 Is Associated with Pathologic Nonresponse to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
inferred← citeshttps://doi.org/10.1016/j.bbcan.2025.189324openalex-snapshot
The duality of GSK-3β in urinary bladder cancer: Tumor suppressor and promoter roles through multiple signaling pathways
inferred← citeshttps://doi.org/10.1016/j.ccell.2025.05.002openalex-snapshot
Microbial cancer immunotherapy reprograms hematopoiesis to enhance myeloid-driven anti-tumor immunity
inferred← citeshttps://doi.org/10.1016/j.clgc.2025.102351openalex-snapshot
Phenotypic Diversity of Immunosuppressive B Cells Associated in Urothelial Carcinoma of the Bladder
inferred← citeshttps://doi.org/10.1016/j.coi.2017.06.007openalex-snapshot
BCG — old workhorse, new skills
inferred← citeshttps://doi.org/10.1016/j.cpt.2023.11.004openalex-snapshot
Theories behind Bacillus Calmette-Guérin failure in high-risk non-muscle-invasive bladder cancer and update on current management
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2022.103893openalex-snapshot
The prognostic impact of tumor-infiltrating B lymphocytes in patients with solid malignancies: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.csbj.2022.11.052openalex-snapshot
Landscape of the intratumroal microenvironment in bladder cancer: Implications for prognosis and immunotherapy
inferred← citeshttps://doi.org/10.1016/j.ejca.2018.12.010openalex-snapshot
Stromal lymphocyte infiltration is associated with tumour invasion depth but is not prognostic in high-grade T1 bladder cancer
inferred← citeshttps://doi.org/10.1016/j.euf.2018.07.032openalex-snapshot
Predicting Response to Intravesical Therapy in Non–muscle-invasive Bladder Cancer
inferred← citeshttps://doi.org/10.1016/j.euf.2018.10.010openalex-snapshot
Building on a Solid Foundation: Enhancing Bacillus Calmette-Guérin Therapy
inferred← citeshttps://doi.org/10.1016/j.euo.2018.07.001openalex-snapshot
A New Twist to an Old Tale: Immunotherapy in Non–muscle-invasive Bladder Cancer
inferred← citeshttps://doi.org/10.1016/j.euo.2023.03.002openalex-snapshot
Adaptive Immunity in Genitourinary Cancers
inferred← citeshttps://doi.org/10.1016/j.eururo.2017.10.003openalex-snapshot
Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review
inferred← citeshttps://doi.org/10.1016/j.eururo.2018.06.045openalex-snapshot
Conventional and PD-L1-expressing Regulatory T Cells are Enriched During BCG Therapy and may Limit its Efficacy
inferred← citeshttps://doi.org/10.1016/j.eururo.2020.06.019openalex-snapshot
Re: Greater Utility of Molecular Subtype Rather than Epithelial-to-mesenchymal Transition (EMT) Markers for Prognosis in High-risk Non-muscle-invasive (HGT1) Bladder Cancer
inferred← citeshttps://doi.org/10.1016/j.eururo.2022.09.008openalex-snapshot
Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guérin Failure in Patients with Non–muscle-invasive Bladder Cancer
inferred← citeshttps://doi.org/10.1016/j.eururo.2025.09.4138openalex-snapshot
Genomic and Transcriptomic Profiling of High-risk Bladder Cancer Reveals Diverse Molecular and Microenvironment Ecosystems
inferred← citeshttps://doi.org/10.1016/j.heliyon.2020.e05556openalex-snapshot
Prognostic significance of CD4-positive regulatory T cells in tumor draining lymph nodes from patients with bladder cancer
inferred← citeshttps://doi.org/10.1016/j.humpath.2016.09.003openalex-snapshot
Immune-checkpoint status in penile squamous cell carcinoma: a North American cohort
inferred← citeshttps://doi.org/10.1016/j.intimp.2019.105880openalex-snapshot
A review on the role of M2 macrophages in bladder cancer; pathophysiology and targeting
inferred← citeshttps://doi.org/10.1016/j.isci.2026.114676openalex-snapshot
BCG immunotherapy for bladder cancer triggers systemic and local BCG-specific CD4+ Th1 responses
inferred← citeshttps://doi.org/10.1016/j.jneuroim.2024.578402openalex-snapshot
Toxoplasma gondii infection supports the infiltration of T cells into brain tumors
inferred← citeshttps://doi.org/10.1016/j.labinv.2025.104120openalex-snapshot
Roles for Androgen Receptor, ADAR2, and PD-L1 in Primary Urothelial Carcinoma In Situ of the Bladder Treated with Bacillus Calmette–Guérin Therapy
inferred← citeshttps://doi.org/10.1016/j.pdpdt.2023.103574openalex-snapshot
Intravesical BCG therapy with photodynamic diagnosis-guided transurethral resection of bladder tumors improves recurrence-free survival
inferred← citeshttps://doi.org/10.1016/j.ucl.2019.09.003openalex-snapshot
Salvage Therapies for Non–muscle-invasive Bladder Cancer: Who Will Respond to Bacillus Calmette-Guérin? Predictors and Nomograms
inferred← citeshttps://doi.org/10.1016/j.ucl.2019.09.005openalex-snapshot
Predictors of Response to Intravesical Therapy
inferred← citeshttps://doi.org/10.1016/j.ucl.2019.09.006openalex-snapshot
Genomic and Therapeutic Landscape of Non-muscle-invasive Bladder Cancer
inferred← citeshttps://doi.org/10.1016/j.ucl.2020.10.005openalex-snapshot
The Tumor Microenvironment and Immunotherapy in Prostate and Bladder Cancer
inferred← citeshttps://doi.org/10.1016/j.urolonc.2019.02.001openalex-snapshot
Therapeutic rationale of targeting BCG and immune checkpoints in non–muscle-invasive bladder cancer: Is this the Future?
inferred← citeshttps://doi.org/10.1016/j.urolonc.2019.08.013openalex-snapshot
Prognostic impact of tumor-associated immune cell infiltrates at radical cystectomy for bladder cancer
inferred← citeshttps://doi.org/10.1016/j.urolonc.2020.04.009openalex-snapshot
PD-1 topographically defines distinct T cell subpopulations in urothelial cell carcinoma of the bladder and predicts patient survival
inferred← citeshttps://doi.org/10.1016/j.urolonc.2020.09.031openalex-snapshot
Bacillus Calmette-Guerin (BCG): Its fight against pathogens and cancer
inferred← citeshttps://doi.org/10.1016/j.urolonc.2022.05.013openalex-snapshot
Immune mechanisms and molecular therapeutic strategies to enhance immunotherapy in non–muscle invasive bladder cancer
inferred← citeshttps://doi.org/10.1016/j.urolonc.2024.11.017openalex-snapshot
FOXP3/TLS; a prognostic marker in patients with bladder carcinoma without muscle invasion
inferred← citeshttps://doi.org/10.1016/j.ygyno.2025.01.001openalex-snapshot
PD-L1-Expression in primary and recurrent vulvar squamous cell cancer
inferred← citeshttps://doi.org/10.1016/s1762-0953(26)50318-2openalex-snapshot
Mode d’action et principes d’utilisation des instillations endovésicales
inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.5c01678openalex-snapshot
Anticancer Efficacy of HPPH-PDT Synergies with BCG-Immunotherapy or COX-2 Inhibitor in Treating Bladder Cancer
inferred← citeshttps://doi.org/10.1021/acsami.6c01301openalex-snapshot
In-Situ Self-Assembling Multifunctional Peptide-Hydrogel Enables Efficient Bladder Cancer Therapy via Sustained Release of Bacillus Calmette-Guérin and Enhanced Immune Response
inferred← citeshttps://doi.org/10.1038/s41389-017-0013-7openalex-snapshot
Unwrapping the genomic characteristics of urothelial bladder cancer and successes with immune checkpoint blockade therapy
inferred← citeshttps://doi.org/10.1038/s41467-022-28509-zopenalex-snapshot
RETRACTED ARTICLE: Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer
inferred← citeshttps://doi.org/10.1038/s41541-020-00278-0openalex-snapshot
The double-sided effects of Mycobacterium Bovis bacillus Calmette–Guérin vaccine
inferred← citeshttps://doi.org/10.1038/s41585-018-0055-4openalex-snapshot
Mechanisms of BCG immunotherapy and its outlook for bladder cancer
inferred← citeshttps://doi.org/10.1038/s41585-019-0226-yopenalex-snapshot
The multifaceted immune regulation of bladder cancer
inferred← citeshttps://doi.org/10.1038/s41598-018-33253-wopenalex-snapshot
Intravesical Mycobacterium brumae triggers both local and systemic immunotherapeutic responses against bladder cancer in mice
inferred← citeshttps://doi.org/10.1038/s41598-021-95157-6openalex-snapshot
MyD88-dependent BCG immunotherapy reduces tumor and regulates tumor microenvironment in bladder cancer murine model
inferred← citeshttps://doi.org/10.1080/07357907.2024.2308161openalex-snapshot
Immune Cell Infiltration Types as Biomarkers for the Recurrence Diagnosis and Prognosis of Bladder Cancer
inferred← citeshttps://doi.org/10.1080/14737140.2017.1313119openalex-snapshot
Tackling non-muscle invasive bladder cancer in the clinic
inferred← citeshttps://doi.org/10.1080/14737140.2020.1822743openalex-snapshot
Novel anticancer therapy in BCG unresponsive non-muscle-invasive bladder cancer
inferred← citeshttps://doi.org/10.1080/2162402x.2018.1476816openalex-snapshot
Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer
inferred← citeshttps://doi.org/10.1080/2162402x.2019.1602460openalex-snapshot
Combined assessment of peritumoral Th1/Th2 polarization and peripheral immunity as a new biomarker in the prediction of BCG response in patients with high-risk NMIBC
inferred← citeshttps://doi.org/10.1080/2162402x.2020.1776060openalex-snapshot
Serum CCL27 predicts the response to Bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer
inferred← citeshttps://doi.org/10.1080/2162402x.2022.2051845openalex-snapshot
Mycobacterial surface characters remodeled by growth conditions drive different tumor-infiltrating cells and systemic IFN-γ/IL-17 release in bladder cancer treatment
inferred← citeshttps://doi.org/10.1080/2162402x.2024.2438291openalex-snapshot
Characterisation of the tumour microenvironment and PD-L1 granularity reveals the prognostic value of cancer-associated myofibroblasts in non-invasive bladder cancer
inferred← citeshttps://doi.org/10.1080/21645515.2023.2267301openalex-snapshot
Knowledge-map analysis of bladder cancer immunotherapy
inferred← citeshttps://doi.org/10.1080/21645515.2024.2440165openalex-snapshot
State of the art of adjuvant immunotherapy in urothelial cancer: New developments and upcoming changes
inferred← citeshttps://doi.org/10.1080/23808993.2020.1768845openalex-snapshot
Prognostic models to help predict patient responses to intravesical immunotherapy
inferred← citeshttps://doi.org/10.1084/jem.20240496openalex-snapshot
Deconvoluting the interplay of innate and adaptive immunity in BCG-induced nonspecific and TB-specific host resistance
inferred← citeshttps://doi.org/10.1097/mcc.0000000000000978openalex-snapshot
Severe infections in recipients of cancer immunotherapy: what intensivists need to know
inferred← citeshttps://doi.org/10.1097/md.0000000000035722openalex-snapshot
E2F3/5/8 serve as potential prognostic biomarkers and new therapeutic direction for human bladder cancer
inferred← citeshttps://doi.org/10.1097/mou.0000000000000546openalex-snapshot
Tissue biomarkers in nonmuscle-invasive bladder cancer
inferred← citeshttps://doi.org/10.1097/pai.0000000000000872openalex-snapshot
Urothelial Carcinoma In Situ of the Bladder: Correlation of CK20 Expression With Adaptive Immune Resistance, Response to BCG Therapy, and Clinical Outcome
inferred← citeshttps://doi.org/10.1097/pap.0000000000000161openalex-snapshot
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and…
inferred← citeshttps://doi.org/10.1101/2023.10.26.564112openalex-snapshot
Comprehensive Landscape of Non-muscle Invasive Bladder Cancer Tumour Microenvironment and Prognostic value of Cancer-Associated Myofibroblasts
inferred← citeshttps://doi.org/10.1101/2024.03.21.586166openalex-snapshot
Microbial cancer immunotherapy reprograms hematopoiesis to enhance anti-tumor immunity
inferred← citeshttps://doi.org/10.1109/bhi50953.2021.9508569openalex-snapshot
Utility of High-Throughput Imaging Mass Cytometry for Cancer Research: A feasibility study
inferred← citeshttps://doi.org/10.1111/apm.13011openalex-snapshot
Bacillus Calmette–Guérin immunotherapy for bladder cancer: a review of immunological aspects, clinical effects and BCG infections
inferred← citeshttps://doi.org/10.1111/bju.15276openalex-snapshot
Value of tumour‐infiltrating immune cells in predicting response to intravesical BCG in patients with non‐muscle‐invasive bladder cancer: a systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1111/bju.15582openalex-snapshot
Predictive value of immunological markers after bacille Calmette–Guérin induction in bladder cancer
inferred← citeshttps://doi.org/10.1111/cas.13560openalex-snapshot
High IDO ‐1 expression in tumor endothelial cells is associated with response to immunotherapy in metastatic renal cell carcinoma
inferred← citeshttps://doi.org/10.1111/sji.12818openalex-snapshot
Toll‐like receptors: The role in bladder cancer development, progression and immunotherapy
inferred← citeshttps://doi.org/10.1126/scitranslmed.abn4118openalex-snapshot
Non–muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin
inferred← citeshttps://doi.org/10.1128/cmr.00194-23openalex-snapshot
Review of BCG immunotherapy for bladder cancer
inferred← citeshttps://doi.org/10.1128/cmr.00212-24openalex-snapshot
BCG therapy in bladder cancer and its tumor microenvironment interactions
inferred← citeshttps://doi.org/10.1134/s0003683820050129openalex-snapshot
Vaccines Against Tuberculosis: Problems and Prospects (Review)
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-19-1920openalex-snapshot
Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials
inferred← citeshttps://doi.org/10.1158/1078-0432.ccr-21-0205openalex-snapshot
Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer
inferred← citeshttps://doi.org/10.1177/23523735251325100openalex-snapshot
Serum metabolomic analysis identified serum biomarkers predicting tumour recurrence after Bacillus Calmette–Guérin therapy in patients with non-muscle invasive bladder cancer
inferred← citeshttps://doi.org/10.1186/s13148-022-01234-6openalex-snapshot
Immune profiles and DNA methylation alterations related with non-muscle-invasive bladder cancer outcomes
inferred← citeshttps://doi.org/10.1186/s43046-026-00340-3openalex-snapshot
Comprehensive Evaluation of Bacillus Calmette–Guérin therapy in Non-muscle invasive bladder cancer Egyptian patients: a retrospective cohort study
inferred← citeshttps://doi.org/10.1371/journal.pone.0233676openalex-snapshot
Mitotic activity index and CD25+ lymphocytes predict risk of stage progression in non-muscle invasive bladder cancer
inferred← citeshttps://doi.org/10.15761/tr.1000170openalex-snapshot
Role of tumor microenvironment in the efficacy of BCG therapy
inferred← citeshttps://doi.org/10.18632/aging.202150openalex-snapshot
A TP53-based immune prognostic model for muscle-invasive bladder cancer
inferred← citeshttps://doi.org/10.18632/oncotarget.17872openalex-snapshot
Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma
inferred← citeshttps://doi.org/10.18632/oncotarget.19913openalex-snapshot
PD-L1 expression in bladder cancer and metastasis and its influence on oncologic outcome after cystectomy
inferred← citeshttps://doi.org/10.18632/oncotarget.25334openalex-snapshot
Prognostic roles of tumor associated macrophages in bladder cancer: a system review and meta-analysis
inferred← citeshttps://doi.org/10.18632/oncotarget.26122openalex-snapshot
Enhanced expression of PD-L1 in non-muscle-invasive bladder cancer after treatment with Bacillus Calmette-Guerin
inferred← citeshttps://doi.org/10.18632/oncotarget.v9i38openalex-snapshot
Prognostic roles of tumor associated macrophages in bladder cancer: a system review and meta-analysis
inferred← citeshttps://doi.org/10.21037/tau.2019.01.15openalex-snapshot
Prediction tools in non-muscle invasive bladder cancer
inferred← citeshttps://doi.org/10.21203/rs.2.11176/v1openalex-snapshot
Immune Cell Infiltration in Bladder Cancer
inferred← citeshttps://doi.org/10.2147/ott.s237099openalex-snapshot
Biological and Clinical Significance of GATA3 Detected from TCGA Database and FFPE Sample in Bladder Cancer Patients
inferred← citeshttps://doi.org/10.21886/2308-6424-2022-10-4-155-164openalex-snapshot
Laboratory predictors to intravesical BCG therapy response in patients with non-muscle invasive bladder cancer
inferred← citeshttps://doi.org/10.31083/fbl47606openalex-snapshot
Decoding Immune Mechanisms in BCG-unresponsive Non-muscle Invasive Bladder Cancer
inferred← citeshttps://doi.org/10.31083/j.fbl2908295openalex-snapshot
Update on the Mechanism of Action of Intravesical BCG Therapy to Treat Non-Muscle-Invasive Bladder Cancer
inferred← citeshttps://doi.org/10.31265/usps.161openalex-snapshot
Better prognostic markers for nonmuscle invasive papillary urothelial carcinomas
inferred← citeshttps://doi.org/10.31393/reports-vnmedical-2019-23(1)-22openalex-snapshot
The prognostic value of immunocellular infiltration of non-invasive urothelial bladder cancer
inferred← citeshttps://doi.org/10.3233/blc-180175openalex-snapshot
Immunology, Immunotherapy, and Translating Basic Science into the Clinic for Bladder Cancer
inferred← citeshttps://doi.org/10.3233/blc-180206openalex-snapshot
CD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and Prognosis
inferred← citeshttps://doi.org/10.3233/blc-190211openalex-snapshot
A Clinical Trial of the Intradermal TLR2 Agonist CADI-05 for BCG Recurrent and Unresponsive Non-Muscle Invasive Bladder Cancer
inferred← citeshttps://doi.org/10.32604/or.2023.028163openalex-snapshot
A Th2-score in the tumor microenvironment as a predictive biomarker of response to Bacillus Calmette Gu閞in in patients with non-muscle invasive bladder carcinoma: A retrospective study
inferred← citeshttps://doi.org/10.32948/auo.2025.02.01openalex-snapshot
Immunotherapies to Nano-Immunotherapies: Advances in Immune Targeting in Bladder Cancer
inferred← citeshttps://doi.org/10.3389/fcell.2025.1719978openalex-snapshot
Evolving frontiers in bladder cancer immunotherapy: integrating BCG, immune checkpoints, viral vectors, nanotechnology, and CAR-based therapies
inferred← citeshttps://doi.org/10.3389/fimmu.2020.615091openalex-snapshot
Immunological Hallmarks for Clinical Response to BCG in Bladder Cancer
inferred← citeshttps://doi.org/10.3389/fimmu.2021.724107openalex-snapshot
A Transcriptional Signature of IL-2 Expanded Natural Killer Cells Predicts More Favorable Prognosis in Bladder Cancer
inferred← citeshttps://doi.org/10.3389/fimmu.2022.963877openalex-snapshot
Immune status for monitoring and treatment of bladder cancer
inferred← citeshttps://doi.org/10.3389/fimmu.2022.993401openalex-snapshot
Remodeling the bladder tumor immune microenvironment by mycobacterial species with changes in their cell envelope composition
inferred← citeshttps://doi.org/10.3389/fimmu.2026.1885439openalex-snapshot
Complement tumor-crosstalk: the role of C5a receptors in urothelial carcinomas
inferred← citeshttps://doi.org/10.3389/fonc.2020.00175openalex-snapshot
Modifying the Non-muscle Invasive Bladder Cancer Immune Microenvironment for Optimal Therapeutic Response
inferred← citeshttps://doi.org/10.3389/fonc.2021.788365openalex-snapshot
Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting
inferred← citeshttps://doi.org/10.3389/fonc.2022.947446openalex-snapshot
Non-muscle invasive bladder cancer biomarkers beyond morphology
inferred← citeshttps://doi.org/10.3389/fonc.2023.1217095openalex-snapshot
Emerging applications of cancer bacteriotherapy towards treatment of pancreatic cancer
inferred← citeshttps://doi.org/10.3389/fonc.2026.1908307openalex-snapshot
Immunotherapy role in bladder cancer treatment: a review of literature
inferred← citeshttps://doi.org/10.3389/fpsyt.2026.1833449openalex-snapshot
CD163+ perivascular macrophages in schizophrenia: a research framework for testing macrophage-related mechanisms
inferred← citeshttps://doi.org/10.3390/app152212032openalex-snapshot
Tumor-Infiltrating Immune Cells in Non-Muscle-Invasive Bladder Cancer: Prognostic Implications, Predictive Value, and Future Perspectives
inferred← citeshttps://doi.org/10.3390/biomedicines14092098openalex-snapshot
Molecular Classifications and Candidate Biomarkers for Personalizing BCG Therapy in Non-Muscle-Invasive Bladder Cancer
inferred← citeshttps://doi.org/10.3390/biomedicines9111500openalex-snapshot
Tumor-Associated Mast Cells in Urothelial Bladder Cancer: Optimizing Immuno-Oncology
inferred← citeshttps://doi.org/10.3390/cancers12113153openalex-snapshot
Clinical Impact of Tumor-Infiltrating Lymphocytes and PD-L1-Positive Cells as Prognostic and Predictive Biomarkers in Urological Malignancies and Retroperitoneal Sarcoma
inferred← citeshttps://doi.org/10.3390/cancers13061323openalex-snapshot
NFκB-Activated COX2/PGE2/EP4 Axis Controls the Magnitude and Selectivity of BCG-Induced Inflammation in Human Bladder Cancer Tissues
inferred← citeshttps://doi.org/10.3390/cancers13184712openalex-snapshot
Tumor-Associated Macrophages in Bladder Cancer: Biological Role, Impact on Therapeutic Response and Perspectives for Immunotherapy
inferred← citeshttps://doi.org/10.3390/cancers14122996openalex-snapshot
Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers
inferred← citeshttps://doi.org/10.3390/cancers14133073openalex-snapshot
BCG in Bladder Cancer Immunotherapy
inferred← citeshttps://doi.org/10.3390/cancers14174192openalex-snapshot
Paving the Way to Solid Tumors: Challenges and Strategies for Adoptively Transferred Transgenic T Cells in the Tumor Microenvironment
inferred← citeshttps://doi.org/10.3390/cancers15041205openalex-snapshot
CD8+ Cell Density Gradient across the Tumor Epithelium–Stromal Interface of Non-Muscle Invasive Papillary Urothelial Carcinoma Predicts Recurrence-Free Survival after BCG Immunotherapy
inferred← citeshttps://doi.org/10.3390/cancers16132299openalex-snapshot
Photodynamic Diagnosis and Therapy in Non-Muscle-Invasive Bladder Cancer
inferred← citeshttps://doi.org/10.3390/cancers18060938openalex-snapshot
Spatial Immune Profiling and AI-Based Classifiers Identify Predictors of BCG Therapy Outcomes in High-Risk Non-Muscle-Invasive Bladder Cancer
inferred← citeshttps://doi.org/10.3390/cells11243991openalex-snapshot
Acute Kidney Injury in Cancer Immunotherapy Recipients
inferred← citeshttps://doi.org/10.3390/cells13080699openalex-snapshot
Breaking Barriers: Modulation of Tumor Microenvironment to Enhance Bacillus Calmette–Guérin Immunotherapy of Bladder Cancer
inferred← citeshttps://doi.org/10.3390/cells13231937openalex-snapshot
Exploring the Immunoresponse in Bladder Cancer Immunotherapy
inferred← citeshttps://doi.org/10.3390/diseases7020044openalex-snapshot
Clinical Impact of the Increase in Immunosuppressive Cell-Related Gene Expression in Urine Sediment during Intravesical Bacillus Calmette-Guérin
inferred← citeshttps://doi.org/10.3390/ijms18102186openalex-snapshot
Regulatory T Cells and Tumor-Associated Macrophages in the Tumor Microenvironment in Non-Muscle Invasive Bladder Cancer Treated with Intravesical Bacille Calmette-Guérin: A Long-Term Follow-Up Study of a Japanese Cohort
inferred← citeshttps://doi.org/10.3390/ijms19020418openalex-snapshot
Synthesis of a Cleaved Form of Osteopontin by THP-1 Cells and Its Alteration by Phorbol 12-Myristate 13-Acetate and BCG Infection
inferred← citeshttps://doi.org/10.3390/ijms21155497openalex-snapshot
Targeting of CD163+ Macrophages in Inflammatory and Malignant Diseases
inferred← citeshttps://doi.org/10.3390/ijms22062818openalex-snapshot
Cell Therapies in Bladder Cancer Management
inferred← citeshttps://doi.org/10.3390/ijms25063105openalex-snapshot
Strategies for Overcoming Immune Evasion in Bladder Cancer
inferred← citeshttps://doi.org/10.3390/ijms25094776openalex-snapshot
Spatial Distribution of Macrophage and Lymphocyte Subtypes within Tumor Microenvironment to Predict Recurrence of Non-Muscle-Invasive Papillary Urothelial Carcinoma after BCG Immunotherapy
inferred← citeshttps://doi.org/10.3390/ijms252413296openalex-snapshot
Loss of Glutathione-S-Transferase Theta 2 (GSTT2) Modulates the Tumor Microenvironment and Response to BCG Immunotherapy in a Murine Orthotopic Model of Bladder Cancer
inferred← citeshttps://doi.org/10.3390/jcm10040764openalex-snapshot
Expression of ADAM Proteases in Bladder Cancer Patients with BCG Failure: A Pilot Study
inferred← citeshttps://doi.org/10.3390/life10100231openalex-snapshot
The Impact of a New Interleukin-2-Based Immunotherapy Candidate on Urothelial Cells to Support Use for Intravesical Drug Delivery
inferred← citeshttps://doi.org/10.3390/pharmaceutics16081067openalex-snapshot
Revitalizing Bacillus Calmette–Guérin Immunotherapy for Bladder Cancer: Nanotechnology and Bioengineering Approaches
inferred← citeshttps://doi.org/10.35841/jmot.1000102openalex-snapshot
Harnessing B Cells for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.35841/medical-oncology.1.1.8-13openalex-snapshot
Harnessing B Cells for Cancer Immunotherapy
inferred← citeshttps://doi.org/10.35841/medical-oncology.1000103openalex-snapshot
Cancer and Their therapeutics
inferred← citeshttps://doi.org/10.35988/sm-hs.2022.222openalex-snapshot
FACTORS PREDICTING THE OUTCOME OF BCG (BACILLUS CALMETTE-GUERIN) THERAPY
inferred← citeshttps://doi.org/10.3892/ol.2018.8173openalex-snapshot
High expression of B7-H3 and CD163 in cancer tissues indicates malignant clinicopathological status and poor prognosis of patients with urothelial cell carcinoma of the bladder
inferred← citeshttps://doi.org/10.3892/ol.2019.10015openalex-snapshot
Determination of the complexity and diversity of the TCR β‑chain CDR3 repertoire in bladder cancer using high‑throughput sequencing
inferred← citeshttps://doi.org/10.3892/ol.2020.11841openalex-snapshot
High expression of EMP1 predicts a poor prognosis and correlates with immune infiltrates in bladder urothelial carcinoma
inferred← citeshttps://doi.org/10.4132/jptm.2022.11.06openalex-snapshot
Significance of tumor-associated neutrophils, lymphocytes, and neutrophil-to-lymphocyte ratio in non-invasive and invasive bladder urothelial carcinoma
inferred← citeshttps://doi.org/10.4149/neo_2020_200202n101openalex-snapshot
Cancer-associated fibroblasts promote cell proliferation and invasion via paracrine Wnt/IL1β signaling pathway in human bladder cancer
inferred← citeshttps://doi.org/10.46879/ukroj.4.2023.391-403openalex-snapshot
Prognostic value of a panel of immunohistochemical markers for determining the risk of recurrence and progression of non-invasive bladder cancer
inferred← citeshttps://doi.org/10.48083/rvzv1144openalex-snapshot
Predictive Biomarkers in the Management of Bladder Cancer: Perspectives in an Evolving Therapeutic Landscape
inferred← citeshttps://doi.org/10.70675/d21e56eez7d33z4293za3f7z06097e64c862openalex-snapshot
Polymorphismes des gènes associés à l’inflammation et microenvironnement tumoral lymphocytaire CD8+ : valeur pronostique dans les carcinomes urothéliaux de la vessie.
inferred← citeshttps://doi.org/10.7150/jca.90085openalex-snapshot
BCG immunotherapy promotes tumor-derived T-cell activation through the FLT3/FLT3LG pathway in bladder cancer
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.